Get started
Author

Karen Zakalik

Observed name: Zakalik, Karen
OpenAlex ID: A5036718136
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
2017 · James F Howard, Kimiaki Utsugisawa, et al. · The Lancet Neurology · 889
Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial
2020 · James F. Howard, Richard J. Nowak, et al. · JAMA Neurology · 205
PDF
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension
2020 · Renato Mantegazza, Gil I. Wolfe, et al. · Neurology · 87
PDF
Eculizumab improves fatigue in refractory generalized myasthenia gravis
2019 · Henning Andersen, Renato Mantegazza, et al. · Quality of Life Research · 61
PDF
Higher weight in adolescence and young adulthood is associated with an earlier age at multiple sclerosis onset
2014 · Katelyn S Kavak, Barbara E Teter, et al. · Multiple Sclerosis Journal · 58
Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study
2019 · Hiroyuki Murai, Akiyuki Uzawa, et al. · Journal of the Neurological Sciences · 24
PDF
COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections
2022 · Dejan Jakimovski, Karen Zakalik, et al. · Vaccines · 22
PDF
Improvement in time to multiple sclerosis diagnosis: 25-year retrospective analysis from New York State MS Consortium (NYSMSC)
2022 · Dejan Jakimovski, Katelyn S Kavak, et al. · Multiple Sclerosis Journal · 19
Patient-reported outcomes based on discontinuation or continuous treatment with natalizumab: New York State Multiple Sclerosis Consortium (NYSMSC) study
2023 · Dejan Jakimovski, Katelyn S. Kavak, et al. · Journal of the Neurological Sciences · 6
A prospective study to validate the expanded timed get-up-and-go in a population with multiple sclerosis
2022 · Dejan Jakimovski, Katelyn S Kavak, et al. · Multiple Sclerosis Journal - Experimental Translational and Clinical · 4
Change in Expanded Timed Get-Up-and-Go is Associated with the Expanded Disability Status Scale and Timed 25-Foot Walk in the New York State Multiple Sclerosis Consortium (4110)
2020 · Bianca Weinstock-Guttman, Katelyn Kavak, et al. · Neurology
Pregnancy Decision-making for Women with Multiple Sclerosis (P4.159)
2014 · Barbara Teter, Katelyn Kavak, et al. · Neurology
Parity Associated with Long-Term Disease Progression in Women with Multiple Sclerosis (P02.130)
2013 · Barbara Teter, Katelyn Kavak, et al. · Neurology
Works count: 15
Citation count: 1,375
H-index: 8
I10-index: 8
Year
Topic
Type